Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbCellera Biologics

2.52
+0.07002.86%
Post-market: 2.520.00000.00%16:30 EDT
Volume:3.32M
Turnover:8.34M
Market Cap:750.93M
PE:-4.55
High:2.53
Open:2.46
Low:2.46
Close:2.45
Loading ...
Jul 22, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 19, 2022

Major Issues Report

8-K - Current report
Jul 06, 2022

Major Issues Report

8-K - Current report
Jun 30, 2022

Major Issues Report

8-K - Current report
Jun 21, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Dec 07, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities